ZhuZhou QianJin Pharmaceutical Co.,Ltd
Símbolo: 600479.SS
SHH
10.91
CNYPrecio de mercado actual
17.9517
Ratio PER
0.4616
Ratio PEG
4.56B
Capitalización MRK
- 0.03%
Rendimiento DIV
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 6888.47 | 1997.9 | 1731.7 | 1369.7 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | -97.51 | -45.7 | 491.7 | 736.8 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 4356.41 | 967 | 983.9 | 921.6 | |||||||||||||||||||||||
balance-sheet.row.inventory | 2227.63 | 534.1 | 599 | 547.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 281.2 | 15.4 | 198.9 | 78.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 13753.71 | 3514.5 | 3513.5 | 2917.3 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2371.59 | 589.9 | 622.8 | 630.2 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 56.3 | 14.1 | 14.1 | 14.1 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 906.1 | 238.3 | 221.8 | 219.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 962.39 | 252.3 | 235.9 | 233.7 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 965.47 | 293.3 | -304.1 | -546.1 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 68.79 | 22.7 | 6.6 | 4.1 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 141.8 | 4.2 | 547.3 | 821 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 4510.04 | 1162.4 | 1108.5 | 1143 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 18263.75 | 4676.9 | 4622 | 4060.2 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 2617.36 | 647.5 | 780.9 | 511.7 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 279.3 | 78.2 | 79.5 | 88.6 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 218.03 | 70.6 | 72.5 | 35.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 144.84 | 38.5 | 44.8 | 60.3 | |||||||||||||||||||||||
Deferred Revenue Non Current | 155.79 | 38 | 44.4 | 51.3 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 78.35 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 280.05 | 69.1 | 705.6 | 75.5 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 407.36 | 108.3 | 108.5 | 131.9 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 110.84 | 31.5 | 32.8 | 44.8 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 6493.32 | 1650.1 | 1805.7 | 1360.3 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 1716.69 | 428.9 | 429.8 | 418.5 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 4286.33 | 1142.5 | 970.8 | 930.7 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 2362.59 | 280.8 | 275.3 | 298.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 933.42 | 537.5 | 540.3 | 503 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 9299.03 | 2389.7 | 2216.2 | 2150.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 18263.75 | 4676.9 | 4622 | 4060.2 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 2471.4 | 637.1 | 600.1 | 549.5 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 11770.43 | 3026.8 | 2816.3 | 2699.9 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 18263.75 | - | - | - | |||||||||||||||||||||||
Total Investments | 867.96 | 247.6 | 187.6 | 190.8 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 424.14 | 116.7 | 124.2 | 148.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | -6414.01 | -1881.2 | -1115.7 | -484 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 278.61 | 395 | 388.3 | 374.7 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 14.07 | 103.7 | 95.6 | 85.9 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -73.79 | -2.8 | -3.6 | 2.7 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 18.19 | 2.8 | 3.6 | -2.7 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 53.6 | -81.7 | 246.9 | 65.8 | ||||||||||||||||||||||
cash-flows.row.account-receivables | -8.69 | -8.7 | -163.7 | 275.9 | ||||||||||||||||||||||
cash-flows.row.inventory | 62.29 | 62.3 | -51.2 | -52.4 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -132.5 | 465.4 | -160.4 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.8 | -3.6 | 2.7 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 191.12 | 26.1 | 2.7 | -40.9 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 474.21 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -36.4 | -44 | -34.4 | -71.9 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.06 | 0 | 0.2 | 30.8 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -100.06 | -402 | -2102 | -1570 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 357.66 | 1031.2 | 2258.4 | 1567.7 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 75.41 | 0.1 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 221.32 | 585.3 | 122.1 | -43.3 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | -50.72 | -50.7 | -15 | -127.6 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 1.41 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -3.38 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | -165.13 | -147.9 | -248.6 | -429.5 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | -17.62 | -13.1 | -0.5 | 36.5 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -219.51 | -202 | -264.2 | -520.6 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -8.88 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 467.14 | 826.4 | 591.4 | -78.3 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 6497.52 | 1928.3 | 1101.9 | 510.5 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 6030.38 | 1101.9 | 510.5 | 588.8 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 474.21 | 443.1 | 733.5 | 485.6 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | -36.4 | -44 | -34.4 | -71.9 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 437.81 | 399.1 | 699 | 413.7 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3839.03 | 3798.5 | 4026.3 | 3663.8 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 2054.9 | 2046.7 | 2289.9 | 2032.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 1784.14 | 1751.8 | 1736.4 | 1631.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 185.64 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 68.58 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 884.41 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -840.99 | -3337.9 | 218.6 | 189.1 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1892.94 | 3337.9 | 1311.7 | 1261.1 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3399.17 | 3337.9 | 3601.5 | 3293.4 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 48.46 | 51.4 | 9.8 | 11.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 1.26 | 1.7 | 2.2 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 884.41 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1.23 | -1.5 | 1.6 | -2.8 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -840.99 | -3337.9 | 218.6 | 189.1 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -1.23 | -1.5 | 1.6 | -2.8 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 1.26 | 1.7 | 2.2 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -79.84 | 103.7 | 104.2 | 47.3 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 486.32 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 465.79 | 460.6 | 444.2 | 436.2 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 464.56 | 459.1 | 445.8 | 433.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 66.62 | 65.4 | 57.6 | 58.7 | |||||||||||||||||||||||
income-statement-row.row.net-income | 278.61 | 320.4 | 302.5 | 302.1 |
Preguntas frecuentes
Cuánto es ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) activos totales?
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) los activos totales son 4676882466.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 2020321390.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.465.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 1.021.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.073.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.121.
¿Qué es ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 320405834.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 116705915.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 3337921320.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 1800315939.000.